Department of Radiology
Found 29 results
Filters: Keyword is Glioma  [Clear All Filters]
2023
Mahase SS, Roytman M, O'Brien DRoth, Ivanidze J, Schwartz TH, Pannullo SC, Ramakrishna R, Magge RS, Williams N, Fine HA et al..  2023.  Concurrent immunotherapy and re-irradiation utilizing stereotactic body radiotherapy for recurrent high-grade gliomas.. Cancer Rep (Hoboken). 6(7):e1788.
Kiser K, Zhang J, Das ABharadwaj, Tranos JA, Wadghiri YZaim, Kim SGene.  2023.  Evaluation of cellular water exchange in a mouse glioma model using dynamic contrast-enhanced MRI with two flip angles.. Sci Rep. 13(1):3007.
Kiser K, Zhang J, Kim SGene.  2023.  Textural Features of Mouse Glioma Models Measured by Dynamic Contrast-Enhanced MR Images with 3D Isotropic Resolution.. Tomography. 9(2):721-735.
2021
Zhang J, Lemberskiy G, Moy L, Fieremans E, Novikov DS, Kim SGene.  2021.  Measurement of cellular-interstitial water exchange time in tumors based on diffusion-time-dependent diffusional kurtosis imaging.. NMR Biomed. 34(6):e4496.
2020
Chiang GC, Pisapia DJ, Liechty B, Magge R, Ramakrishna R, Knisely J, Schwartz TH, Fine HA, Kovanlikaya I.  2020.  The Prognostic Value of MRI Subventricular Zone Involvement and Tumor Genetics in Lower Grade Gliomas.. J Neuroimaging. 30(6):901-909.
Shen Z, Tung C-H.  2020.  Selective photo-ablation of glioma cells using an enzyme activatable photosensitizer.. Chem Commun (Camb). 56(89):13860-13863.
2019
Zhang S, Liu Z, Nguyen TD, Yao Y, Gillen KM, Spincemaille P, Kovanlikaya I, Gupta A, Wang Y.  2019.  Clinical feasibility of brain quantitative susceptibility mapping.. Magn Reson Imaging. 60:44-51.
Seligman L, Kovanlikaya I, Pisapia DJ, Naeger DM, Magge R, Fine HA, Chiang GC.  2019.  Integrated PET-MRI for Glioma Surveillance: Perfusion-Metabolism Discordance Rate and Association With Molecular Profiling.. AJR Am J Roentgenol. 212(4):883-891.
Zhang S, Chiang GChia-Yi, Magge RS, Fine HAlan, Ramakrishna R, Chang EWang, Pulisetty T, Wang Y, Zhu W, Kovanlikaya I.  2019.  MRI based texture analysis to classify low grade gliomas into astrocytoma and 1p/19q codeleted oligodendroglioma.. Magn Reson Imaging. 57:254-258.
Zhang S, Chiang GChia-Yi, Magge RS, Fine HAlan, Ramakrishna R, Chang EWang, Pulisetty T, Wang Y, Zhu W, Kovanlikaya I.  2019.  Texture analysis on conventional MRI images accurately predicts early malignant transformation of low-grade gliomas.. Eur Radiol. 29(6):2751-2759.
2018
Citak-Er F, Firat Z, Kovanlikaya I, Ture U, Ozturk-Isik E.  2018.  Machine-learning in grading of gliomas based on multi-parametric magnetic resonance imaging at 3T.. Comput Biol Med. 99:154-160.
2017
Wang M, Kommidi H, Tosi U, Guo H, Zhou Z, Schweitzer ME, Wu LY, Singh R, Hou S, Law B et al..  2017.  A Murine Model for Quantitative, Real-Time Evaluation of Convection-Enhanced Delivery (RT-CED) Using an [F]-Positron Emitting, Fluorescent Derivative of Dasatinib.. Mol Cancer Ther. 16(12):2902-2912.
2016
Reynaud O, Winters KVeronica, Hoang DMinh, Wadghiri YZaim, Novikov DS, Kim SGene.  2016.  Pulsed and oscillating gradient MRI for assessment of cell size and extracellular space (POMACE) in mouse gliomas.. NMR Biomed. 29(10):1350-63.
Reynaud O, Winters KVeronica, Hoang DMinh, Wadghiri YZaim, Novikov DS, Kim SGene.  2016.  Surface-to-volume ratio mapping of tumor microstructure using oscillating gradient diffusion weighted imaging.. Magn Reson Med. 76(1):237-47.
2011
Boockvar JA, Tsiouris AJ, Hofstetter CP, Kovanlikaya I, Fralin S, Kesavabhotla K, Seedial SM, Pannullo SC, Schwartz TH, Stieg P et al..  2011.  Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article.. J Neurosurg. 114(3):624-32.
2008
Kim S, Pickup S, Hsu O, Poptani H.  2008.  Diffusion tensor MRI in rat models of invasive and well-demarcated brain tumors.. NMR Biomed. 21(3):208-16.
Luther N, Cheung N-KV, Dunkel IJ, Fraser JF, Edgar MA, Gutin PH, Souweidane MM.  2008.  Intraparenchymal and intratumoral interstitial infusion of anti-glioma monoclonal antibody 8H9.. Neurosurgery. 63(6):1166-74;discussion1174.
2006
Balmaceda C, Critchell D, Mao X, Cheung K, Pannullo S, DeLaPaz RL, Shungu DC.  2006.  Multisection 1H magnetic resonance spectroscopic imaging assessment of glioma response to chemotherapy.. J Neurooncol. 76(2):185-91.
2005
Shah K, Tung C-H, Breakefield XO, Weissleder R.  2005.  In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis.. Mol Ther. 11(6):926-31.
Lamfers MLM, Gianni D, Tung C-H, Idema S, Schagen FHE, Carette JE, Quax PHA, Van Beusechem VW, W Vandertop P, Dirven CMF et al..  2005.  Tissue inhibitor of metalloproteinase-3 expression from an oncolytic adenovirus inhibits matrix metalloproteinase activity in vivo without affecting antitumor efficacy in malignant glioma.. Cancer Res. 65(20):9398-405.
2004
Shah K, Tung C-H, Chang C-H, Slootweg E, O'Loughlin T, Breakefield XO, Weissleder R.  2004.  In vivo imaging of HIV protease activity in amplicon vector-transduced gliomas.. Cancer Res. 64(1):273-8.
Shah K, Tung C-H, Yang K, Weissleder R, Breakefield XO.  2004.  Inducible release of TRAIL fusion proteins from a proapoptotic form for tumor therapy.. Cancer Res. 64(9):3236-42.
Messerli SM, Prabhakar S, Tang Y, Shah K, Cortes ML, Murthy V, Weissleder R, Breakefield XO, Tung C-H.  2004.  A novel method for imaging apoptosis using a caspase-1 near-infrared fluorescent probe.. Neoplasia. 6(2):95-105.
2003
Xu S, Gade TPF, Matei C, Zakian K, Alfieri AA, Hu X, Holland EC, Soghomonian S, Tjuvajev J, Ballon D et al..  2003.  In vivo multiple-mouse imaging at 1.5 T.. Magn Reson Med. 49(3):551-7.
2002
Ntziachristos V, Tung C-H, Bremer C, Weissleder R.  2002.  Fluorescence molecular tomography resolves protease activity in vivo.. Nat Med. 8(7):757-60.